下一个

自动播放

Targeting of NSCLC in 2011 by Alice Shaw, MD, PhD

6 意见 • 07/30/23
分享
嵌入
administrator
administrator
订户
0

Dr. Shaw describes the current data supporting the use of EGFR and ALK targeted therapies in treating molecularly genotyped patients with advanced NSCLC at the 2011 Chabner Colloquium.

显示更多
0 注释 sort 排序方式
脸书评论

下一个

自动播放